42388
73211
ITI Pharma and Healthcare Fund Growth
19.63
3.21
2.36
0.30
7.16
5.88
11.79
7
1.71
19.63
ITI Pharma and Healthcare Fund (G)
1.71
19.63
1.11
3.5
3 Years
  • NAV

    16.67

    09 Jun 2026

  • 1.00%

     1 Day

  • 19.63%

    3Y CAGR returns

One click to compare funds with our smart tool—analyze returns & more! Compare
  • ₹ 500

    Min SIP
  • ₹ 5000

    Min Lumpsum
  • 2.38%

    Expense Ratio
  • 1

    Rating
  • 230 Cr

    Fund Size
  • 4 Years

    Fund Age

SIP Calculator

Yr
  • Invested Amount
  • ₹ 00
  • Wealth Gained
  • ₹ 00
  • Expected Amount
  • ₹ 00
Yr
  • Invested Amount
  • ₹ 00
  • Wealth Gained
  • ₹ 00
  • Expected Amount
  • ₹ 00

Returns and Ranks ( as on 09 Jun 2026 )

  • 1Y Returns
  • 3Y Returns
  • 5Y Returns
  • MAX Returns
  • Trailing Returns
  • 3.21%
  • 19.63%
  • 11.79
  • -3.57Alpha
  • 4.73SD
  • 0.92Beta
  • 0.68Sharpe
  • Exit Load
  • If redeemed/Switched out on or before 3 Months from the date of allotment Exit Load is 0.50% Exit Load after completion of 3 months - NIL
  • Tax implication
  • Returns redeemed within a year are taxed at 20%, while those held longer incur a 12.5% LTCG tax on gains over Rs 1.25 lakh per financial year.
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Animesh Singh

Low Low to
moderate
Moderate Moderately
High
High Very
High
  • Fund Name
73211
  • Fund Name
  • Address :
  • ITI House 36, Dr.R.K.Shirodkar Marg, Parel Mumbai - 400012.
    • Contact :
    • +91022-66214999
    • Email ID :
    • mfassist@itiorg.com
Mutual Fund by Category

Large Cap

  • Fund Name

Mid Cap

Multi Cap

ELSS

Focused

Sectoral / Thematic

Small Cap

Dividend Yield

Ultra Short Duration

Liquid Mutual

Gilt Mutual

Long Duration

Overnight Mutual

Floater Mutual

Arbitrage Mutual

Equity Savings Mutual

Aggressive Hybrid Mutual

FAQs

ITI Pharma and Healthcare Fund Growth has delivered 12.07% since inception

The NAV of ITI Pharma and Healthcare Fund Growth is ₹16.7296 as of 09 Jun 2026

The expense ratio of ITI Pharma and Healthcare Fund Growth is 2.38 % as of 09 Jun 2026

The AUM of ITI Pharma and Healthcare Fund Growth 229.56 CR as of 09 Jun 2026

The minimum SIP amount of ITI Pharma and Healthcare Fund Growth is 500

The top stock holdings of ITI Pharma and Healthcare Fund Growth are

  1. Sun Pharma.Inds. - 12.40%
  2. Divi's Lab. - 8.83%
  3. Apollo Hospitals - 6.25%
  4. Max Healthcare - 5.22%
  5. Torrent Pharma. - 4.82%

The top sectors ITI Pharma and Healthcare Fund Growth has invested in are

  1. - 0%

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form